Abstract-Effects of (-)cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl
Abstract-Effects of (-)cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl 1,5-benzothiazepin-4-(5H)-one hydrochloride (BTM-1086) on various experimental gastric and duodenal ulcers were studied in rats. In the pylorus-ligated ulcer, restraint and water immersion stress ulcer , and drug-induced ulcer (indomethacin, aspirin, reserpine, serotonin, cysteamine), BTM-1086 prevented the development of ulcer at a dose of 0.1 to 1 mg/kg, p.o., but only weakly inhibited the histamine induced gastric ulcer. The inhibitory activities of BTM-1086 were significantly higher than those of atropine sulfate.
In the healing experiment with the acetic acid-induced stomach ulcer, BTM-1086 (1 mg/kg/day , p.o., x14) showed a significant healing effect, which was higher than that of propantheline bromide . BTM-1086 at a dose of 0.2 mg/kg , i.d., remarkably inhibited the gastric secretion 6 hr after pylorus ligation.
The aspirin-induced reductions of the total acid and K+ as well as the increments of the volume and Na+ in the gastric secretion were prevented dose-dependently by pretreatment with BTM-1086.
Among derivatives of benzothiazepine, diltiazem is widely known as a Ca antagonist, but other pharmacological activities of this group have not been described. We screened a series of synthesized benzothiazepine derivatives for phar macologic activities. One of these deriva tives, (-)-cis-2,3-dihydro-3-(4-methyl piperazinylmethyl) 2 phenyl 1,5 benzo thiazepin-4(5H)-one hydrochloride (BTM  1086) (1-4), was found to have anti ulcerous activity. The present study was designed to assess its effect on several types of experimental ulcers and gastric acid secretion in comparison with pharmacological activities of such drugs as atropine sulfate and propantheline bromide. 
Materials and Methods

BTM-1086
with a molecular weight of 403.97, the chemical structure of which is shown in Fig. 1 (5) . After 18 hr, the animals were sacrificed and the stomachs were removed. The stomachs were opened along the greater curvature and were macroscopically ex amined. Drugs were administered p.o. at the time of pyloric ligation. The severity of the gastric ulcer was scored according to an arbitrary scale and expressed as the "Ulcer Index". 0=no lesion, 1 =one to three small ulcers (3 mm or smaller), 2=more than three small ulcers or large ulcer, 3=one large and several small ulcers, 4=several large ulcers, and 5=perforated
ulcers. 2) Stress-induced ulcers: The stress ulcers were produced following the method described by Takagi et al. (6) and Takagi and Okabe (7) . Rats weighing 202 to 252 g were fasted for 24 hr before immersing into water. Each drug was given p.o. 30 min before the stress. These rats were fixed by the limbs on a wire-netting and immersed to the depth of the xiphoid in a water bath at 23'C. The rats were autopsied after 7 hr of the stress. The stomach of each rat was removed, inflated by injecting 7.5 ml of 1 % formalin solution, and immersed in 1 % formalin solution for 20 min to fix the inner and outer layers of the gastric walls. The stomach was then incised along the greater curvature and examined for ulcers developed in the glandular portion. The "Ulcer Index" was calculated as the sum of the length (mm) of each ulcer in the stomach.
3) Indomethacin-induced ulcers: This ulcer model was induced according to the method of Somogi et al. (8) . Rats weighing 178 to 192 g were fasted for 24 hr and given 20 mg/ kg of indomethacin, p.o. Drugs were given p.o. to the rats 10 min before the indomethacin treatment. The animals were sacrificed by a blow on the head 7 hr later, and the stomachs were removed and examined for ulcers in the glandular portion. The sum of the length (mm) of all ulcers for each rat was used as the ulcer index. 4) Aspirin-induced ulcers in pylorus ligated rats: Rats weighing 206 to 210 g were deprived of food for 24 hr. According to the method described by Okabe et al. (9) , the pylorus of each animal was ligated under ether anesthesia. At 1 5 min after the ligation, 100 mg/kg of aspirin suspended in 1 % gum arabic solution was given p.o. in a volume of 0.3 ml/100 g of body weight, and then the test drugs were given intraduodenally (i.d.) immediately after the ligation. Seven hr later, the animals were sacrificed, their stomachs removed, and the gastric contents were collected.
Subsequently, the stomach was incised along the greater curvature and examined for the presence of ulcers in the glandular portion. Lengths (mm) of ulcers were totaled for each animal as the ulcer index. The gastric contents collected were centrifuged and analyzed for volume, pH, acidity and peptic activity. The acidity was measured by titration with 0.02N NaOH to pH 7.0 using an electromatic pH-meter and expressed as mEq/L. The acid output was expressed as mEq/7 hr. The peptic activity was determined for the non-diluted gastric juice from pyloric ligated rats, according to Anson's method (10) using bovine hemo globin as a substrate; and it was expressed as mg of tyrosine/hr. The concentrations of Na+ and K+ ions in the gastric juice were measured with a flamephotometer (Hira numa FPF-3A type).
5) Reserpine-induced ulcers: Rats weigh ing 185 to 228 g were fasted for 24 hr, and given 5 mg/kg of reserpine i.p. Drugs were given p.o. to the rats 10 min before the reserpine treatment. The animals were sacrificed by a blow on the head 18 hr later, and the stomachs were removed and opened along the greater curvature. The total areas (mm2) of the gastric ulcers were measured as the ulcer index.
6) Serotonin-induced ulcers: Rats weigh ing 184 to 206 g were fasted for 24 hr, given 20 mg/kg of serotonin-creatinine sulfate s.c. Test drugs were given s.c. 1 hr prior to the injection of serotonin.
The animals were sacrificed by a blow on the head 18 hr later, and the stomachs were removed and opened along the greater curvature. The total areas (mm2) of the gastric ulcers were measured as the ulcer index.
7) Histamine-induced ulcers: Rats weigh ing 190 to 216 g were fasted for 24 hr, but were provided with water ad libitum. This ulcer model was induced according to the method of Buchner et al. (111) . Each rat was administered 300 mg/kg of histamine hydro chloride i.p. The animals, deprived of solid food and water for 4 hr, were sacrificed and their stomachs removed to examine the ulcers in the glandular portion. The sum of the length (mm) of all ulcers was used as an ulcer index. Drugs were administered p.o. 10 min before the administration of histamine hydrochloride.
8) Cysteamine-induced duodenal ulcers: Rats weighing 199 to 214 g were used . Duodenal ulcer was induced by the method of Fujii and Ishii (12) by injecting s.c. 400 mg/kg of cysteamine hydrochloride (Tokyo Kasei Kogyo). Test drugs were given 5 hr prior to injection of cysteamine. The animals were sacrificed by a blow on the head 18 hr later, and the stomach and duodenum of each rat were excised to determine the presence of duodenal ulcers. In this particular ulcer model, the sum of the area (mm2) of ulcers for each rat was measured under a dissecting micro scope (x 10) with a square. 9) Acetic acid-induced gastric ulcers: The experiment was carried out according to the method of Takagi et al. (13) . Rats weigh ing 180 to 190 g were anesthesized with ether and subjected to laparotomy to expose the stomach after which 20 gal of 20% acetic acid was injected carefully under the serous membrane of the abdominal side in the glandular stomach; then the abdomen was closed. Thereafter, the animals were fed normally and 5 ml/kg of each test drug dissolved or suspended in 0.5% gum arabic solution was administered p.o. once daily for 14 days from the second day after the operation. Animals were removed and treated as described for the stress-induced ulceration. The longitudinal and abscissal length of the areas were quickly measured with a calliper, and the multiplied product was used as the ulcer index.
Gastric secretion
Gastric secretion in pylorus ligated rats: Rats weighing about 200 g, fasted for 24 hr, were anesthetized with ether and then pylorus-ligated.
Drugs were dissolved in distilled water and administered i.d. im mediately after pylorus-ligation.
Six hr after the pylorus-ligation, the contents of the stomach were collected; and the volume of gastric juice, acidity and peptic activity were determined by the methods as described for the aspirin-induced ulceration.
Statistics
Results are shown as the mean+standard error. Statistical significance was determined by Student's t-test. The gastric contents were analyzed as shown in Table 4 -2. In the pylorus-ligated rats without aspirin, the volume of gastric juice was 25 ml/100 g b.w. The acidity, the Na+ content, the K+ content and the peptic activity in the gastric juice were 60 mEq/L, 60 mEq/L, 1 3 mEq/L and 41 mg-tyrosine/hr, respectively. In the pylorus-ligated rats with aspirin, the volume of gastric juice and Na+ concentration were significantly higher, but the acidity was lower than those of rats without aspirin. The reductions of total acid and K+ as well as the increments of the volume and Na+ provoked by aspirin were prevented dose-dependently by the pre treatment with BTM-1086, while the pH of gastric juice was not affected. (Table 8) .
9) Acetic acid-induced gastric ulcers: As shown in Table 9 , BTM-1086 given at doses of 1, 5 and 20 mg/kg daily for 14 days showed a significant healing effect on acetic acid induced ulcer; the healing indexes were 39.1% (P<0.05), 42.2% (P<0.05) and 48.4% (P<0.01), respectively. Propantheline bromide did not show a significant healing effect under the conditions used.
Gastric secretion
Gastric secretion in pylorus-ligated rats:
The volume of gastric secretion, acid output and pepsin activity were measured as shown in Table 10 . The treatment with BTM-1086 (0.05-5 mg/kg, i.d.) or atropine sulfate (0.5 10 mg/kg, i.d.) significantly decreased the volume of gastric secretion, acid output and pepsin activity, but did not affect the pH of the gastric juice. The ED50 values for decreasing the volume were 0.11 mg/kg and 5 mg/kg for BTM-1086 and atropine sulfate, respectively. For decreasing the acid output, similar ED50 values were obtained. However, the ED50 values for decreasing pepsin activity were 0.04 mg/kg and 2.2 mg/kg for BTM-1086 and atropine sulfate, respectively, which were 2.2-fold lower than those for the volume and output. Discussion It is evident from the present data that the new synthetic compound BTM-1086 inhibits the development of various types of acute ulcers induced in the stomach and duodenum of rats. The anti -ulcerogenic effects of the compound on ulcers induced in rats by stress, aspirin, indomethacin or reserpine were found to be conspicuous. Histamine induced ulcers in rats were also observed to be suppressed by the compound.
The ED50 value of BTM-1086 was determined to be 0.06 to 2.6 mg/kg in these animal models for acute gastroduodenal ulceration. In view of its oral LD50 value being 880 mg/kg in rats, this compound provides a relatively wide safety margin.
Kitagawa et al. (14) observed a significant increase of gastric secretion in rats placed under stressful conditions, suggesting pos sible involvement of gastric secretion in the pathogenesis of stress ulcer. However, it is important to take other factors into con sideration, e.g., gastric hypermotility. Greater importance has become attached recently to diminution of regional blood flow which is a protective factor (15) (16) (17) . Friction of the gastric mucosa per se is thought to be an important factor besides decreased resis tibility of the gastric mucosa rather than gastric acid (18-21 ). It is noteworthy, in relation to these effects, that a profound inhibitory effect was observed with BTM 1086 on aspirin and indomethacin-induced ulcerations. Since a strong involvement of endogenous prostaglandins (PGs) in the development of gastric ulcer associated with the use of these nonsteroidal anti-inflam matory agents has been demonstrated (22) , it would be reasonable to infer that BTM 1086 may stimulate biosynthesis or release of endogenous PGs.
In the pathogenesis of aspirin-induced ulcer, it is assumed that inhibition of pro staglandin synthesis leads to gastric hypersecretion, hence augmentation of the aggressive factor. The damage to the mucosal barrier by direct action of aspirin would give rise to influx of water and sodium ion into the gastric lumen and back diffusion of acid into the gastric mucosa, with consequent liberation of histamine from mast cells. This may result in capillary hyperpermeability and hemorrhagic injuries, hence diminution of the protective factor. BTM-1086 has been proven to inhibit the back diffusion of acid against development of aspirin-induced ulcer when administered at doses of 0.05 mg/kg, i.d. The data obtained seem to indicate, therefore, that the compound exerted anti ulcerogenic and antipeptic activity via the reduction of gastric juice output and inhibition of acid secretion.
With regard to the pathogenetic mecha nism of reserpine-induced gastric ulceration, the enhanced gastric secretion due to the histamine release evoked by reserpine has been incriminated. Kagoshima and Suguro (23, 24) have postulated that hypermotility of the stomach, which brings about ischemia of the gastric mucosa with involvement of catecholamines and biogenic amines, leads to vasomotor imbalance, and after consequent depletion of endogenous catecholamines, vagotonic hypermotility plays a major part in the development of ulcer. Serotonin-induced ulcer is generally thought to arise from a disturbance of gastric mucosal microcircu lation. Reserpine and serotonin-induced gastric ulcerations were significantly inhibited by BTM-1086. Since the development of ulcers by these agents usually takes about 18 hr, it is suggested that the action of BTM 1086 is remarkably long-sustained and that the compound may suppress gastric hyper motility and improve local microcirculation besides its effect on gastric secretion.
According to the report of Okabe et al. (25) , histamine-induced gastric ulcer is considered to be due not only to gastric hypersecretion but to the diminution of protective factors on the part of the mucosa as well. BTM-1086 had a rather modest inhibitory effect on histamine ulcer as com pared to its effects on other experimental models for acute ulceration.
The antiulcerogenic action of BTM-1086 is extremely long-sustained in that the com pound given 5 hr before the administration of cysteamine produced a marked inhibition of the development of duodenal ulcer which usually takes 18 hr.
Antacids and anticholinergic agents which are inhibitors of aggressive factors are ineffective for promotion of healing of acetic acid-induced ulcer which presents a striking resemblance in histopathologic features to chronic gastric ulcer in man. Conversely, a significant delay in acetic acid ulcer healing was observed with propantheline and atropine (29, 30) . The healing of this experi mental ulcer was hastened by pirenzepine, an anti -chol1nergic, selective muscarinic an tagonist, and also by H2-receptor antagonists (25, 31) . The noticeable effect of BTM-1086 on promoting ulcer healing may be inter preted as implying that increased mucosal blood flow brought about by the compound took part in the repairing process of injured tissue. It has been shown by Takayanagi and coworkers (32) that BTM-1086 inhibits acetylcholine liberation from the parasympa thetic nerve endings.
The effectiveness of BTM-1086 on acetic acid ulcer and increased blood flow in the gastric mucosa observed following its administration (33) indicate that the augmen tation of protective factors such as mucosal regeneration and improvement of mucosal constituents contribute to its antiulcerogenic activity. The results, therefore, suggest the potential clinical usefulness of BTM-1086 as a drug which suppresses such aggressive factors as acid secretion and peptic activity and also augments protective factors.
